Proteasomal Inhibition Potentiates Latent HIV Reactivation
- 5 October 2020
- journal article
- research article
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 36 (10) , 800-807
Abstract
Despite the success of antiretroviral therapy (ART), ART fails to eradicate the virus and HIV cure has remained beyond the reach of current treatments. ART targets replicating virally infected but not latently infected cells, which have limited expression of factors important for proliferation and cellular activity, including positive transcription elongation factor b (P-TEFb) and nuclear factor κB (NF-κB). Levels of the cyclin T1 (CycT1) subunit of P-TEFb are low to absent in resting T cells, and treatment with proteasome inhibitors (PIs) increases CycT1 protein levels to those of proliferating T cells. In this study, the clinically approved PI bortezomib reactivated latent HIV in latently infected primary CD4+ T cells. Bortezomib not only increased levels of CycT1 but also activated NF-κB. Strikingly, as opposed to most currently researched latency reversing agents (LRAs), bortezomib did not require a second LRA to potently reactivate latent HIV. Effects of bortezomib on resting T cells and reactivation of HIV suggest a possible direction for future attempts to diminish the viral reservoir in HIV+ individuals.Keywords
This publication has 41 references indexed in Scilit:
- Histone Deacetylase Inhibitors (HDACis) That Release the Positive Transcription Elongation Factor b (P-TEFb) from Its Inhibitory Complex Also Activate HIV TranscriptionJournal of Biological Chemistry, 2013
- Cyclin T1 and CDK9 T-Loop Phosphorylation Are Downregulated during Establishment of HIV-1 Latency in Primary Resting Memory CD4+T CellsJournal of Virology, 2013
- Bromodomain and Extra-terminal (BET) Bromodomain Inhibition Activate Transcription via Transient Release of Positive Transcription Elongation Factor b (P-TEFb) from 7SK Small Nuclear RibonucleoproteinJournal of Biological Chemistry, 2012
- Shock and killNature, 2012
- Effect of Histone Deacetylase Inhibitors on HIV Production in Latently Infected, Resting CD4+ T Cells From Infected Individuals Receiving Effective Antiretroviral TherapyThe Journal of Infectious Diseases, 2012
- Mechanisms of HIV Transcriptional Regulation and Their Contribution to LatencyMolecular Biology International, 2012
- Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse EventsClinical Cancer Research, 2011
- Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose‐modification guidelineBritish Journal of Haematology, 2009
- Signaling to NF-κBGenes & Development, 2004
- Effects of Prostratin on T-Cell Activation and Human Immunodeficiency Virus LatencyJournal of Virology, 2002